166 related articles for article (PubMed ID: 12072086)
21. [CD8-positive, CD30-negative cutaneous T-cell lymphoma simulating pyoderma gangrenosum].
Dueck D; Hermes B; Audring H; Kohl PK
Hautarzt; 2002 Feb; 53(2):114-7. PubMed ID: 11963190
[TBL] [Abstract][Full Text] [Related]
22. Primary cutaneous lymphomas: a study of 37 cases.
Andrès P; Lepagney ML; Bureau B; Litoux P; Dréno B
Int J Dermatol; 1997 Aug; 36(8):582-6. PubMed ID: 9329888
[TBL] [Abstract][Full Text] [Related]
23. Primary cutaneous CD30-positive large cell lymphoma.
Freitas IC; Vieira R; Afonso A; Pacheco A; Nunes P
J Eur Acad Dermatol Venereol; 2000 Jan; 14(1):51-3. PubMed ID: 10877252
[TBL] [Abstract][Full Text] [Related]
24. Brentuximab vedotin therapy for CD30-positive cutaneous T-cell lymphoma: a targeted approach to management.
Scarisbrick JJ
Future Oncol; 2017 Nov; 13(27):2405-2411. PubMed ID: 28805086
[TBL] [Abstract][Full Text] [Related]
25. CD30+ lymphoproliferative disorder in a patient with metastatic papillary thyroid carcinoma.
Udkoff J; Cohen PR
Dermatol Online J; 2016 Oct; 22(10):. PubMed ID: 28329586
[TBL] [Abstract][Full Text] [Related]
26. Cutaneous CD30 positive large T cell lymphoma of the upper lip: a rare presentation.
Chandu A; Mitchell DA; Corrigan AM
Br J Oral Maxillofac Surg; 1997 Jun; 35(3):193-5. PubMed ID: 9212298
[TBL] [Abstract][Full Text] [Related]
27. Results of a Phase II Trial of Brentuximab Vedotin for CD30+ Cutaneous T-Cell Lymphoma and Lymphomatoid Papulosis.
Duvic M; Tetzlaff MT; Gangar P; Clos AL; Sui D; Talpur R
J Clin Oncol; 2015 Nov; 33(32):3759-65. PubMed ID: 26261247
[TBL] [Abstract][Full Text] [Related]
28. Primary "cutaneous" T-cell anaplastic large cell lymphoma, CD30+, neutrophil-rich variant with subcutaneous panniculitic lesions, in a post-renal transplant patient: report of unusual case and literature review.
Salama S
Am J Dermatopathol; 2005 Jun; 27(3):217-23. PubMed ID: 15900125
[TBL] [Abstract][Full Text] [Related]
29. Intralymphatic cutaneous anaplastic large cell lymphoma/lymphomatoid papulosis: expanding the spectrum of CD30-positive lymphoproliferative disorders.
Samols MA; Su A; Ra S; Cappel MA; Louissant A; Knudson RA; Ketterling RP; Said J; Binder S; Harris NL; Feldman AL; Kim J; Kim YH; Gratzinger D
Am J Surg Pathol; 2014 Sep; 38(9):1203-11. PubMed ID: 24805854
[TBL] [Abstract][Full Text] [Related]
30. Solitary primary cutaneous CD30+ large cell lymphoma of natural killer cell phenotype bearing the t(2;5)(p23;q35) translocation and presenting in a child.
Gould JW; Eppes RB; Gilliam AC; Goldstein JA; Mikkola DL; Zaim MT; Wood GS
Am J Dermatopathol; 2000 Oct; 22(5):422-8. PubMed ID: 11048978
[TBL] [Abstract][Full Text] [Related]
31. Primary gastric CD30 (Ki-1)-positive large cell non-Hodgkin's lymphomas. A clinicopathologic analysis of six cases.
Paulli M; Rosso R; Kindl S; Boveri E; Bonoldi E; Stracca V; Motta T; Arrigoni G; Lazzarino M; Menestrina F
Cancer; 1994 Feb; 73(3):541-9. PubMed ID: 8299075
[TBL] [Abstract][Full Text] [Related]
32. A case of CD30+ nasal natural killer/T-cell lymphoma.
Ferenczi K; Summers P; Aubert P; Cooper B; Meyerson H; Cooper KD; Honda K
Am J Dermatopathol; 2008 Dec; 30(6):567-71. PubMed ID: 19033930
[TBL] [Abstract][Full Text] [Related]
33. CD30-Positive Lymphoproliferative Disorders.
Nikolaenko L; Zain J; Rosen ST; Querfeld C
Cancer Treat Res; 2019; 176():249-268. PubMed ID: 30596222
[TBL] [Abstract][Full Text] [Related]
34. A case of Sézary's syndrome associated with granulomatous lesions, myelodysplastic syndrome and transformation into CD30-positive large-cell pleomorphic lymphoma.
Carrozza PM; Kempf W; Kazakov DV; Dummer R; Burg G
Br J Dermatol; 2002 Sep; 147(3):582-6. PubMed ID: 12207606
[TBL] [Abstract][Full Text] [Related]
35. A case of primary cutaneous CD30+ T-cell lymphoproliferative disorder with features of granulomatous slack skin disease.
Wada K; Maesawa C; Satoh T; Akasaka T; Masuda T
Br J Dermatol; 2002 Nov; 147(5):998-1002. PubMed ID: 12410714
[TBL] [Abstract][Full Text] [Related]
36. Incidence and ten-year follow-up of primary cutaneous lymphomas: a single-centre cohort study.
Maurelli M; Tessari G; Colato C; Schena D; Girolomoni G
Eur J Dermatol; 2018 Feb; 28(1):44-49. PubMed ID: 29171395
[TBL] [Abstract][Full Text] [Related]
37. CD30 (Ki-1)-positive primary cutaneous T-cell lymphoma: report of spontaneous resolution.
Artemi P; Wong DA; Mann S; Regan W
Australas J Dermatol; 1997 Nov; 38(4):206-8. PubMed ID: 9431717
[TBL] [Abstract][Full Text] [Related]
38. Proapoptotic and antiapoptotic markers in cutaneous T-cell lymphoma skin infiltrates and lymphomatoid papulosis.
Nevala H; Karenko L; Vakeva L; Ranki A
Br J Dermatol; 2001 Dec; 145(6):928-37. PubMed ID: 11899146
[TBL] [Abstract][Full Text] [Related]
39. Primary cutaneous CD30(+) lymphoproliferative disorders.
Wieser I; Tetzlaff MT; Torres Cabala CA; Duvic M
J Dtsch Dermatol Ges; 2016 Aug; 14(8):767-82. PubMed ID: 27509411
[TBL] [Abstract][Full Text] [Related]
40. Progressive epidermotropic CD8+/CD4- primary cutaneous CD30+ lymphoproliferative disorder in a patient with sarcoidosis.
Gelfand JM; Wasik MA; Vittorio C; Rook A; Junkins-Hopkins JM
J Am Acad Dermatol; 2004 Aug; 51(2):304-8. PubMed ID: 15280854
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
